Atomfair

Awaiting product image

Atomfair N4-Acetyl-2′-O-tert-butyldimethylsilylcytidine C17H29N3O6Si

Description N4-Acetyl-2′-O-tert-butyldimethylsilylcytidine (CAS No. 401812-97-3) is a high-purity, chemically modified nucleoside derivative designed for advanced research applications in nucleic acid chemistry and oligonucleotide synthesis. With the molecular formula C17H29N3O6Si , this compound features a tert -butyldimethylsilyl (TBDMS) protecting group at the 2′-hydroxyl position and an acetyl group at the N4 position of cytidine, enhancing its stability and utility in solid-phase RNA synthesis. Its IUPAC name, N-[1-[(2R,3R,4R,5R)-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide , reflects its precise stereochemistry and functionalization. Ideal for researchers developing modified oligonucleotides, this product is rigorously characterized by HPLC, NMR, and mass spectrometry to ensure ??95% purity. Store under inert conditions at -20??C…

Category:
Brands:

Description

Description

N4-Acetyl-2′-O-tert-butyldimethylsilylcytidine (CAS No. 401812-97-3) is a high-purity, chemically modified nucleoside derivative designed for advanced research applications in nucleic acid chemistry and oligonucleotide synthesis. With the molecular formula C17H29N3O6Si, this compound features a tert-butyldimethylsilyl (TBDMS) protecting group at the 2′-hydroxyl position and an acetyl group at the N4 position of cytidine, enhancing its stability and utility in solid-phase RNA synthesis. Its IUPAC name, N-[1-[(2R,3R,4R,5R)-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide, reflects its precise stereochemistry and functionalization. Ideal for researchers developing modified oligonucleotides, this product is rigorously characterized by HPLC, NMR, and mass spectrometry to ensure ??95% purity. Store under inert conditions at -20??C for optimal stability.

  • CAS No: 401812-97-3
  • Molecular Formula: C17H29N3O6Si
  • Molecular Weight: 399.5
  • Exact Mass: 399.18256219
  • Monoisotopic Mass: 399.18256219
  • IUPAC Name: N-[1-[(2R,3R,4R,5R)-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
  • SMILES: CC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O[Si](C)(C)C(C)(C)C
  • Synonyms: 401812-97-3, N4-Acetyl-2′-O-tert-butyldimethylsilylcytidine, N-(1-((2R,3R,4R,5R)-3-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, SCHEMBL6396735, NA71488

Application

N4-Acetyl-2′-O-tert-butyldimethylsilylcytidine is a critical intermediate in the synthesis of modified RNA oligonucleotides, particularly for structural studies and therapeutic applications. The TBDMS group protects the 2′-OH during phosphoramidite-based RNA synthesis, while the N4-acetyl modification enhances nucleoside stability. This compound is widely used in antisense technology, siRNA design, and CRISPR guide RNA production. Its compatibility with automated synthesizers makes it valuable for high-throughput research.

If you are interested or have any questions, please contact us at support@atomfair.com